Sign in
Taking peoplePhase 3

Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates

Key facts

Who runs it
Indian Council of Medical Research
Where
India9 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
1,500 people, planned
Started
7 Jun 2025
Expected to end
May 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Antibiotics
Record updated
27 October 2026

Who can take part

Age
4 hours to 4 hours
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Gestational age of 26 0/7 to 34 6/7 weeks
  • Chronological age 4 hours
  • Have any one or both of the following risk factors of EONS:; Prolonged rupture of membranes >18 hours; Pre-labour rupture of membranes [as all subjects will be preterm, this is effectively pPROM]
  • Are either asymptomatic or have no signs attributable to sepsis at 4 hours. This will be defined as absence of the following clinical signs or need for interventions mentioned below:; Apnea (Standard definition) requiring intervention at any time until enrolment; Need for a fluid bolus or inotropic support at any time until enrolment; Seizures or seizure-like activity at any time until enrolment; Upper GI bleed in the absence of a history of ante-partum hemorrhage at any time until enrolment; Pus from any site at any time until enrolment; Need for CPAP >6 cms of water with FiO2 >35% at 4 hours OR need for CPAP less than or equal to 6 cms and FiO2 less than or equal to 35% but with increasing requirement of support; Chest Xray (if performed) with radiological features of pneumonia; Need for intubation and mechanical ventilation; Temperature >37.5°C or <36°C, unexplained by environmental causes; Feed intolerance [bilious or bloodstained vomiting (or gastric residuals) or visibly distended abdomen or >50% of the previous feed volume as gastric residuals]; Lethargy or unarousability; Sclerema

Who cannot take part

  • Received a dose of antibiotics
  • Positive amniotic fluid culture (if performed and available prior to randomization)
  • Subjects will be excluded if they have any 1 of the following:
  • <!-- -->
  • Life-threatening congenital malformation
  • Severe perinatal asphyxia (Apgar score <5 at 10 minutes or cord pH <7.0)
  • Clinical chorioamnionitis# [see definition below]
  • Foul-smelling liquor
  • Multiple gestation
  • Treating neonatologist unwilling to enroll the patient in the trial on the grounds that the patient needs antibiotics; -

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Sepsis or preterm premature rupture of membrane or preterm birth

This trial is currently available in India.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Preterm infants are born at less than 37 weeks of pregnancy. Sometimes a break or tear in the fluid filled bag that surrounds and protects the infant during pregnancy leads to an untimely birth. This state puts the infant at risk of serious condition called sepsis. Sepsis is a condition in which body responds inappropriately to an infection. Sepsis may progress to septic shock which can result in the loss of life. Doctors give antibiotics to treat sepsis.

Read full original descriptionShow less

The goal of this research study is to find out:

1. Among neonates at risk of early-onset neonatal sepsis, whether a policy of administering antibiotics selectively to a subset of at-risk infants who later develop signs of sepsis is not inferior to administering antibiotics to all at-risk infants in the 1st week of life. 2. To find out if infants receiving selective antibiotics (as above) compared to those receiving antibiotics from soon after birth (as above) require fewer antibiotic courses cumulatively of more than 48 hours duration in the 1st week of life. 3. To find out whether infants receiving selective antibiotics (as above) compared to those receiving antibiotics from soon after birth (as above) are significantly different with respect to a wide range of secondary outcomes (listed under "Outcomes").

The 2 groups in the trial

  • Selective antibiotic groupTreatment being tested

    Antibiotics will be administered selectively to a subset of at-risk neonates who develop clinical signs of sepsis.

    Treatment: Antibiotics

  • Comparison groupExisting treatment, for comparison

    Antibiotics will be pre-emptively administered to all neonates at risk of sepsis.

    Treatment: Antibiotics

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics Therapy for Preterm Neonates At-risk of Early-onset Sepsis: a Multicentric, Randomized, Controlled, Non-inferiority Trial (the SAUNA Trial)
Criteria questions
Built from NCT06377397, who can take part
Record updated
27 October 2026